Showing results (61-70 of 186) with videos related to
Sort By:
Pageof 19
Cell Reports|March 24, 2021
FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold toleranceOliver Stöhr, Rongya Tao, Ji Miao, et al.American Journal of Physiology. Endocrinology and Metabolism|November 18, 2010
Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1Dan Wei, Rongya Tao, Yao Zhang, et al.The Journal of Biological Chemistry|December 23, 2018
Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilizationGang Xi, Xinchun Shen, Christine Wai, et al.Cancer Research|November 5, 2002
Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implicationsQing Chang, Yu Li, Morris F White, et al.Diabetes|June 27, 2013
Direct autocrine action of insulin on β-cells: does it make physiological sense?Christopher J Rhodes, Morris F White, John L Leahy, et al.The Journal of Biological Chemistry|February 12, 2005
Insulin receptor substrate 2 plays diverse cell-specific roles in the regulation of glucose transportMarianna Sadagurski, Galina Weingarten, Christopher J Rhodes, et al.JCI Insight|October 30, 2019
Uncoupled turnover disrupts mitochondrial quality control in diabetic retinopathyJose R Hombrebueno, Lauren Cairns, Louise R Dutton, et al.Plos One|November 20, 2009
Selective inhibition of retinal angiogenesis by targeting PI3 kinaseYolanda Alvarez, Olaya Astudillo, Lasse Jensen, et al.FEBS Letters|January 18, 2011
CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathyBrian Rooney, Helen O'Donovan, Andrew Gaffney, et al.Cell Metabolism|February 8, 2023
The role of hepatokines in NAFLDNorbert Stefan, Fritz Schick, Andreas L Birkenfeld, et al.Pageof 19